National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Which Study Results Are the Most Helpful in Making Cancer Care Decisions?
    Posted: 06/12/2003



Introduction






Clinical Trials Are Experimental & Prospective






What's a Phase III Clinical Trial?






Controlled Studies Allow Comparisons






Randomization: Chance, Not Choice






To Blind or Not to Blind






Study Size Matters






Example 1: A Cancer Treatment Trial






Example 2: A Cancer Prevention Trial






Summary: Questions to Ask About a Cancer Study



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Maintenance Rituximab for Follicular Lymphoma

Azacitidine Improves Survival in MDS

Second Stem Cell Transplant Not Helpful in Myeloma
Controlled Studies Allow Comparisons

In trying to judge how definitive a clinical trial's results are, note whether it was a controlled or uncontrolled trial.

In a controlled clinical trial, one group of participants serves as a control group. These participants do not receive the intervention being studied.

Having a control group in a clinical trial enables investigators to answer the question "Compared to what?" Do participants receiving the intervention (the investigational group) fare better, worse, or the same as those who get standard therapy or a placebo?

In an uncontrolled study, which has no comparison group, investigators cannot be sure whether the outcomes they observe are caused by the intervention, by chance, or by unknown factors.

In a cancer treatment trial, participants in the control group usually receive the current standard treatment for their disease. Only when no standard treatment exists for that particular kind of cancer would participants in the control group receive a placebo, or dummy treatment.

In a cancer prevention trial, participants in the control group may receive an intervention known to help in the prevention of cancer. Those in the experimental group receive the new intervention. In those cases where no proven intervention exists, participants in the control group would receive a placebo.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov